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There is little information on whether prenatal multiple micronutrient (MMN) supplements
containing iodine affect women's iodine status. In the International Lipid‐based Nutrient
Supplements DYAD‐Ghana trial, we aimed to assess women's urinary iodine concentration
(UIC, μg/L) during pregnancy, as one of the planned secondary outcomes. Women (n = 1,320)
<20 weeks of gestation were randomized to consume 60 mg iron and 400 μg folic acid per day
(iron and folic acid [IFA]); 18 vitamins and minerals including 250 μg iodine per day (MMN); or
20 g/day of small‐quantity lipid‐based nutrient supplements (LNS) with the same and additional
4 vitamins and minerals as the MMN (LNS). In a subsample (n = 295), we tested differences in
groups' geometric mean UICs at 36 weeks of gestation controlling for baseline UIC and compared
the geometric means (approximately median UICs) with the World Health Organization (WHO)
cut‐offs: median UIC <150, 150–249, and ≥500 reflecting low, adequate, and excessive iodine
intakes, respectively. At baseline, overall median UIC was 137. At 36 weeks of gestation,
controlling for baseline UIC, geometric mean (95% confidence interval) UICs of the MMN (161
[133, 184]) and LNS (158 [132, 185]) groups did not differ; both values were significantly greater
(overall p = .004) than that of the IFA group (116 [101, 135]). The median UICs of the MMN and
LNS groups were within the WHO “adequate” range, whereas that of the IFA group was below
the WHO adequate range. In this setting, supplementation during pregnancy with small‐quantity
LNS or MMN providing iodine at the WHO‐recommended dose, compared with IFA, increases
the likelihood of adequate iodine status.
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Key messages
• In this semiurban setting in Ghana, the median spot
urinary iodine concentration of pregnant women at
<20 weeks of gestation (137 μg/L) was below the
World Health Organization range (150–249 μg/L) for
adequate iodine intake. Only about one third of the
women reportedly used iodized salt usually, or always,
despite a national salt iodization programme.
• During pregnancy, daily supplementation with multiple
micronutrients or small‐quantity lipid‐based nutrient
supplements, compared with iron and folic acid,
increased the likelihood of adequate iodine status.
• Regular monitoring of the iodine status of pregnant
women is needed to ensure the elimination of iodine
deficiency in Ghana.
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Iodine is needed for the synthesis of thyroid hormones; these
hormones are required for body metabolism and are key in the
development of the central nervous system in fetuses and children
(de Escobar, Obregon, & del Rey, 2007). Consequences of iodine
deficiency disorders (IDD) among women include miscarriage, impaired
mental function, development of goitre, and delivery of stillborn or
neurocognitively impaired infants (United Nations Children's Fund
[UNICEF], 2007; World Health Organization [WHO], 2007).
In 1994, universal salt iodization was recommended as the main
strategy for preventing iodine deficiency (WHO, 1994; WHO, 2007),
and iodized salt consumption has increased since then (Tran, Hetzel,
& Fisher, 2016) due to national salt iodization programmes (UNICEF,
2008; WHO, 2007). Nonetheless, in 2013, 35% of the global popula-
tion was at risk of iodine deficiency because of inadequate intakes
(WHO, 2013), and in Africa, 11 countries remained iodine deficient
(Jooste, Andersson, & Assey, 2013). Thus, despite the substantial prog-
ress in the prevention of IDD, iodine deficiency continues to be a public
health problem in many countries (Tran et al., 2016; UNICEF, 2007).
In 2007, the WHO increased the then Food and Agriculture Orga-
nization of the United Nations recommended nutrient intake for iodine
during pregnancy (Food and Agriculture Organization of the United
Nations/WHO, 2005) from 200 to 250 μg/day (WHO Secretariat et al.,
2007) and called for possible supplementation or food fortification
with iodine for pregnant women in areas where universal salt
iodization is not fully implemented and/or pregnant women might
not be adequately covered by iodized salt in order to ensure optimal
brain development of their infants (WHO/UNICEF, 2007).
The national salt iodization programme in Ghana began more than
two decades ago (Government of Ghana, 1996). According to the 2014
Ghana Demographic and Health Survey (Ghana Statistical Service [GSS]
et al., 2015), only 39% of households in Ghana have adequately iodized
salt (15+ ppm). Along with previous reports (Jooste et al., 2013; UNICEF,
2008), this estimate suggests that many pregnant women in the country
may not consume adequate iodine. Because deficiencies of
micronutrients often occur together and not in isolation (Bailey, West,
& Black, 2015; Haider & Bhutta, 2017; UNICEF/WHO/United Nations
University, 1999), it is possible that pregnant women in Ghana might
benefit from the provision of a multiple micronutrient (MMN) regimen
that includes iodine, as compared with the provision of iodine alone.
In the International Lipid‐based Nutrient Supplements (iLiNS)
DYAD‐Ghana trial, as part of the iLiNS Project, we tested the impact
of prenatal consumption of small‐quantity lipid‐based nutrient
supplements (SQ‐LNS; Arimond et al., 2015) or MMN capsules
on various maternal (Adu‐Afarwuah, Lartey, Okronipa, Ashorn, Zeilani,
et al., 2016; Adu‐Afarwuah et al., 2017) and child (Adu‐Afarwuah
et al., 2015; Adu‐Afarwuah, Lartey, Okronipa, Ashorn, Peerson, et al.,
2016) outcomes. Only a few such studies (Haider & Bhutta, 2017)
comparing the impact of MMN supplementation versus iron and folic
acid [IFA] supplementation during pregnancy have reported on
women's urinary iodine concentration (UIC), even though the elimina-
tion of iodine deficiency is an international priority (UNICEF, 2008). In
the analyses reported herein, we aimed to compare the UIC among the
three groups of pregnant women enrolled in the iLiNS DYAD‐Ghanatrial (UIC was one of the planned secondary outcomes of the trial)
and to assess the groups' iodine intake adequacy on the basis of the
WHO cut‐offs for UIC.2 | METHODS
2.1 | Study setting, design, and participants
The setting, design, and participants of the iLiNS DYAD‐Ghana trial have
been described elsewhere (Adu‐Afarwuah et al., 2015). Briefly, we con-
ducted the study in the semiurban Somanya‐Odumase‐Kpong area,
about 70 km north of Accra, Ghana. The studywas designed as a partially
double‐blind, parallel, individually randomized, controlled trial with three
equal‐size groups andwas approved by the ethics committees of theUni-
versity of California, Davis; the Ghana Health Service; and the University
of Ghana Noguchi Memorial Institute for Medical Research and regis-
tered at clinicaltrials.gov (Identifier NCT00970866).
Between December 2009 and December 2011, pregnant women
attending usual antenatal clinics in the four major health facilities in
the area were screened if they were ≥18 years old; ≤20 weeks of
gestation; and had fully completed antenatal cards. Women were
excluded if any of the following applied: intention to move out of the
area within the next 2 years; milk or peanut allergy; unwillingness to
receive field workers or take study supplement; participation in
another trial; gestational age >20 weeks before completion of enrol-
ment; and antenatal card indicated HIV infection, asthma, epilepsy,
tuberculosis, or malignant disease.
2.2 | Group assignments and micronutrient
supplements
As described previously (Adu‐Afarwuah et al., 2015), after baseline
assessments, pregnant women were randomized to receive either
60 mg iron and 400 μg folic acid per day (hereafter, IFA supplement
or group) or 18 vitamins and minerals (including 20 mg iron) per day
(hereafter, MMN supplement or group) or 20 g/day of SQ‐LNS
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calcium, phosphorus, potassium, and magnesium, as well as energy
(118 kcal/day) and macronutrients (e.g., protein and essential fatty
acids; hereafter, SQ‐LNS or LNS group). The IFA and MMN were sup-
plied by DSM South Africa in 10‐capsule‐blister packs and the SQ‐LNS
by Nutriset S.A.S. (Malaunay, France) in individual 20‐g sachets. The
nutrient contents of the supplements (Adu‐Afarwuah et al., 2015)
and the rationale for the concentrations used (Arimond et al., 2015)
have been published. For most of the vitamins and minerals in the
MMN and SQ‐LNS, the contents were either 1× or 2× the recom-
mended dietary allowance for pregnancy (Arimond et al., 2015), except
for iron (Adu‐Afarwuah, Lartey, Okronipa, Ashorn, Zeilani, et al.,
2016). We included 250 μg/day for iodine based on the WHO
recommendation (WHO Secretariat et al., 2007).
The group assignments were performed as follows: the study
statistician at UC Davis, Janet M. Peerson, used a computer‐
generated (SAS version 9.4) scheme to develop the group alloca-
tions in blocks of 9, with the IFA and MMN groups coded by six
different colours, to maintain blinding. In Ghana, someone unrelated
to the randomization placed the group assignments in opaque
envelopes, which were labelled with the block numbers, sealed,
and stacked in increasing order of block numbers. The labelling
was done in pencil on the side of the envelopes not conspicuous
to the women, so as to not influence the women's choices. At each
enrolment, the study nurse took the topmost nine envelopes off
the stack, shuffled them, and asked the woman to pick one of
the nine envelopes, which revealed the group assignment. The
study nurse then returned the unused envelopes to the top of
the stack. This process continued until all of the envelopes
prepared for the target sample were used. When there were less
than nine women left to be enrolled, it was no longer possible for
a participant to pick one of the nine envelopes, except for
the study nurse to shuffle whatever number of envelopes that
remained, for the women to make a pick. At no point during ran-
domization was it possible for the study nurse to guess the remain-
ing allocations, because she had no knowledge of the randomization
scheme. Any allocation information was kept securely by the field
supervisor in Ghana and the study statistician at UC Davis only.2.3 | Intervention
The intervention procedures were reported previously (Adu‐Afarwuah
et al., 2015; Adu‐Afarwuah, Lartey, Okronipa, Ashorn, Peerson, et al.,
2016). At enrolment, the study nurse gave each woman a 2‐week
supply of the assigned supplement and provided instructions on how
to consume it (IFA and MMN, with water after a meal, one capsule
per day; SQ‐LNS, mixed with any prepared food, one 20‐g sachet per
day). Thereafter, field workers delivered fresh supplies of supplement
and monitored supplement intakes and morbidity biweekly
(Adu‐Afarwuah et al., 2015). Women were told not to consume more
than one capsule (IFA and MMN groups) or sachet (LNS group) per day,
even if they forgot to take the supplement the previous day or days.
Women travelling out of the study area for periods beyond the next
biweekly visit were given extra supplies of supplements for the period
they intended to be away.It was not possible to blind field workers and participants to
women who received the capsules (IFA and MMN) versus those who
received SQ‐LNS, because of the apparent differences between these
supplements. However, the laboratory staff who collected or analysed
the samples were blinded to the group assignments.2.4 | Procedures and outcome measures
At baseline, we collected data on women's demographic and socio‐eco-
nomic characteristics and how often women used iodized salt (whether
never, sometimes, usually, or always). We presumed that women knew
iodized salt versus non‐iodized salt by the packaging and cost (even if
they could not read any labels), because the latter is often not packaged
and costs less. Further, we conducted anthropometric and laboratory
assessments and obtained spot urine samples, which were frozen until
analysed (Adu‐Afarwuah et al., 2015). We measured women's weight
(Seca 874, Seca), height (Seca 217, Seca), mid‐upper arm circumference
(Shorr tapes), and triceps skinfold thickness (Holtain calipers) by using
standard procedures and determined blood haemoglobin concentration
(HemoCue, HemoCue AG), malaria parasitaemia (Vision Biotech), and
gestational age (mostly by ultrasound biometry, Aloka SSD 500). We
calculated the assets index, housing index, and Household Food Insecu-
rity Access Scale score as proxy indicators of background socio‐eco-
nomic status, by using principal component analysis (Coates,
Swindale, & Bilinsky, 2007). At 36 weeks of gestation, we asked the
women again about their frequency of using iodized salt. The women
returned to the laboratory (last laboratory visit before delivery), where-
upon we repeated the collection of spot urine samples.
Urine samples were air‐freighted on dry ice to the laboratories of
the Medical Research Council in Cape Town, South Africa, where UIC
was determined. First, the urine samples were manually digested in a 96‐
well plate by using ammonium persulfate. The digested samples were then
transferred to a newmicroplate for the Sandell–Kolthoff reaction, and UIC
was read at 405 nm (Henjum et al., 2016; Jooste & Strydom, 2010).
The secondary outcomes evaluated here were geometric mean
UIC (μg/L) at 36 weeks of gestation and median change in UIC over
the intervention period.2.5 | Sample size basis and data analysis
For women's UIC during pregnancy (as well as several other biochemical
outcomes in our trial), we based the target sample size on detecting an
effect size or Cohen's d (Cohen, 1988) of ≥0.5 between any two groups,
with a two‐sided 5% test and 80% power. This required 105 women per
group or 315women for the three groups, after taking into account up to
25% attrition. Subsequently, we randomly selected a subsample of 315
women from the 810 women enrolled after we had corrected the
mislabelling situation we reported previously (Adu‐Afarwuah et al.,
2015; Adu‐Afarwuah, Lartey, Okronipa, Ashorn, Peerson, et al., 2016),
to ensure that none of the women in the UIC analyses had been exposed
to unintended supplements during pregnancy. At 36 weeks of gestation,
we had UIC values for 292women, which gave >93%power to detect an
effect size of 0.5 between any two groups.
The analysis for the results presented here was part of the
iLiNS DYAD‐Ghana statistical analysis plan, which was developed and
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the statistical analysis plan and trial protocol at clinicaltrials.gov list
women's UIC as a secondary outcome to be analysed separately. We
analysed data on an intention‐to‐treat basis (by including
women regardless of adherence to treatment) and by using SAS for
Windows Release 9.4 (Cary, NC, USA).We summarized the background
characteristics at enrolment, by group, as mean ± SD or frequency (%).
Because UICs are known to be not normally distributed (WHO, 2013),
we summarized baseline UIC and change in UIC from baseline to
36 weeks of gestation as median (Q1, Q3), by group, and compared
UIC of groups at 36 weeks of gestation after natural log transformation.
The comparison at 36 weeks of gestation was performed by using
analysis of covariance (SAS PROC GLIMMIX), with Tukey adjustment
for multiple comparison. The prespecified variables evaluated as
potential covariates and for interaction in bivariate models were gesta-
tional age at enrolment, years of formal education, parity (nulliparous
or parous), season of enrolment (wet or not wet), household assets
index (by principal component analysis), Household Food Insecurity
Access Scale score (Coates et al., 2007), reported use of iodized salt,
and baseline UIC. The covariate for use of iodized salt was created
from the frequency of using iodized salt at baseline and 36 weeks of
gestation by assigning 0, 1, 2, and 3 to never, sometimes, usually, and
always, respectively, and averaging the coded responses across the
two time points. Values of this covariate ranged from 0 to 3, where
higher values represented higher frequency of use of iodized salt. Only
the prespecified variables significantly associated with the outcome at
<.1 level of significance were included as covariates. Interactions with
p‐for‐interaction <.1 were considered significant.
We performed the analysis of covariance twice: first, with baseline
UIC as the only covariate in the model and, second, with all of theTABLE 1 Background characteristics at enrolment of women randomly se
randomized trial of micronutrient supplementation during pregnancy in a s
Characteristics IFA (n = 94)
Age (years) 26.3 ± 5.2 [92]
Years of formal education (years) 7.8 ± 2.9 [92]
Weight (kg) 63.0 ± 11.6 [91]
Height (cm) 158 ± 5.0 [91]
MUAC (cm) 28.3 ± 4.0 [91]
Triceps skinfold (mm) 19.3 ± 7.1 [91]
Body mass index (kg/m2) 25.1 ± 4.2 [91]
HFIAS scoreb 2.5 ± 3.7 [92]
Gestational age at enrolment (weeks) 16.2 ± 3.0 [92]
Nulliparous women, n/total (%) 37/92 (40.2)
Hb <100 g/L, n/total (%) 9/92 (9.8)
Positive malarial RDT, n/total (%) 4/92 (4.3)
Note. HFIAS = Household Food Insecurity Access Scale; IFA = iron and folic aci
RDT = rapid diagnostic test (Clearview Malarial Combo; Vision Biotech, which de
SQ‐LNS = small‐quantity lipid‐based nutrient supplements; Hb = haemoglobin.
an = 295. IFA group: Women were assigned to receive 60 mg Fe + 400 mg fo
receive 18 vitamins and minerals (including 20 mg Fe) per day during pregnancy
the same micronutrients as the MMN group + calcium, phosphorus, potassium
means ± SDs (n) unless otherwise indicated. n/total indicates the number of pa
number of participants analysed for the variable in question.
bHFIAS score is a proxy indicator for household food insecurity (Coates et al., 2identified covariates in themodel. A visual inspection and a Shapiro–Wilk
test of normality revealed that the residuals of the models were normally
distributed. We obtained the group geometric means of UICs and their
95% confidence intervals by back‐transformation. The geometric mean
UIC is an approximate estimator of median UIC (Hauschke, Steinijans,
& Pigeot, 2007; Thomas, 1990). For prespecified variables with a signifi-
cant interaction, we performed subgroup analyses to determine whether
intervention groups differed in the different subgroups. Each interaction
variable was considered separately in the model to avoid collinearity.
Finally, to assess the adequacy of iodine intakes of groups, we com-
pared the group geometric mean (approximately the group median) UICs
with WHO cut‐off levels: median UIC <150 μg/L representing inade-
quate iodine intakes, median UIC 150–249 μg/L representing adequate
iodine intakes, and UIC ≥500 μg/L representing excessive iodine intakes.
Statistics in the texts are median (Q1, Q3) or geometric mean
(95% confidence interval). We previously reported (Klevor et al.,
2016) that women's adherence to supplement intake during pregnancy
(i.e., percentage of follow‐up days women self‐reportedly consumed
the supplements) was 88.1% for the IFA group; 87.0% for the MMN
group; and 83.7% for the LNS group (Klevor et al., 2016).3 | RESULTS
The data presented here were collected between October 2010 and
June 2012. The background characteristics of women in the subsample
whose spot UICs were analysed are shown inTable 1. These character-
istics were generally balanced across the three groups. There were no
differences in these background characteristics between women in the
subsample and those who were not selected for the UIC analysis
(results not shown), except that the former had greater mean ± SDlected for urinary iodine analysis out of women who participated in a
emiurban setting in Ghana, by groupa
MMN (n = 102) LNS (n = 101)
26.0 ± 5.1 [102] 26.9 ± 5.6 [101]
7.5 ± 3.2 [102] 8.1 ± 3.8 [101]
62.8 ± 11.8 [100] 61.9 ± 9.2 [98]
159 ± 5.7 [100] 159 ± 5.2 [98]
27.8 ± 3.7 [100] 27.8 ± 3.4 [98]
18.5 ± 7.2 [100] 18.7 ± 6.3 [98]
24.8 ± 4.2 [100] 24.6 ± 3.6 [98]
2.2 ± 3.3 [101] 2.1 ± 3.0 [101]
16.1 ± 3.1 [102] 16.1 ± 3.2 [101]
37/102 (36.3) 34/101 (33.7)
19/102 (18.6) 10/101 (9.9)
4/102 (3.9) 9/101 (8.9)
d; LNS = lipid‐based nutrient supplement; MMN = multiple micronutrients;
tected Plasmodium falciparum and non‐P. falciparum histidine‐rich protein 2);
lic acid per day during pregnancy; MMN group: Women were assigned to
; LNS group: Women were assigned to receive 20 g SQ‐LNS per day with
, and magnesium as well as macronutrients during pregnancy. Values are
rticipants whose response was “yes” for the variable in question per total
007); higher values represent higher food insecurity.
ADU‐AFARWUAH ET AL. 5 of 10
bs_bs_banneryears of formal education (7.8 ± 3.3 vs. 7.3 ± 3.6 years; p = .045) and a
lower percentage of women with a positive rapid diagnostic test for
malaria (6% vs. 10%; p = .036). The percentage of women who
reported using iodized salt usually or always was 31% at baseline
and 33% at 36 weeks of gestation. Otherwise, the majority of the
women reported that they never used iodized salt, or they used it
sometimes.
Results of the analysis of the UICs of women, by group at baseline
and 36 weeks of gestation, are presented in Table 2. At baseline, the
median (Q1, Q3) UIC for the MMN group appeared lower than the
overall median (137 [78, 221] μg/L). The median change in UIC from
baseline to 36 weeks of gestation was positive for the MMN and
LNS groups, whereas the reverse was true for the IFA group.TABLE 2 UIC (μg/L) of women who received IFA, MMN, and SQ‐LNS dur
Group
UIC (μg/L) IFA (n = 91)
Baselineb 150 (94, 234)
Change (enrolment to 36 weeks of gestation) −24 (−123, 52)
36 weeks of gestationc 116 (101, 138)e
36 weeks of gestationd 113 (100, 138)e
Note. UIC = urinary iodine concentration; iLiNS = International Lipid‐based Nu
supplements; MMN = multiple micronutrients; SQ‐LNS = small‐quantity lipid‐b
on analysis of covariance (SAS PROC GLIMMIX).
an = 292. IFA group: Women were assigned to receive 60 mg Fe + 400 mg folic a
minerals including 250 μg iodine per day; LNS group: Women were assigned to
group, plus calcium, phosphorus, potassium, and magnesium as well as macronu
bBaseline values are median (Q1, Q3).
cValues at 36 weeks of gestation are geometric means (95% CI) obtained by b
Tukey adjustment for multiple comparison. Geometric mean (95% CI) values wi
dValues at 36 weeks of gestation are geometric means (95% CI) obtained by ba
years of formal education, parity, season of enrolment, and household assets
(95% CI) values with different superscript letters are significant different.
TABLE 3 Geometric mean UIC (μg/L) at 36 weeks of gestation of women
DYAD‐Ghana trial, stratified by subgroups of gestational age at enrolment
Baseline characteristics and subgroups IFAb
Gestational age at enrolment (weeks)
In first trimester (n = 44) 99 (71, 139)e
In second trimester (n = 248) 122 (103, 146)e
Parity
Nulliparous (n = 108) 117 (88, 147)
Parous (n = 184) 109 (97, 149)e
Baseline UIC
UIC ≥ 150 μg/L (n = 147) 140 (112, 175)
UIC < 150 μg/L (n = 145) 100 (79, 126)e
Note. IFA = iron and folic acid; LNS = lipid‐based nutrient supplement; MMN
supplements; UIC = urinary iodine concentration. Analysis at 36 weeks of gesta
an = 292. IFA group: Women were assigned to receive 60 mg Fe + 400 mg folic a
minerals including 250 μg iodine per day; LNS group: Women were assigned to
group, plus calcium, phosphorus, potassium, and magnesium as well as macronu
bValues are geometric means (95% CI), adjusted for variables significantly assoc
years of formal education, parity, season of enrolment, and household assets in
significant different.
cp‐values are for interaction with intervention group.
dp‐values compare all three groups in each stratum.At 36 weeks of gestation, controlling for baseline UIC, the MMN
and LNS groups did not differ significantly in geometric mean UIC,
but each of these groups had a geometric mean UIC that was signifi-
cantly greater than that of the IFA group. These results remained
unchanged after controlling for additional background variables. The
geometric mean (approximately median) UICs of the MMN and LNS
groups were each greater than 150 μg/L, the WHO cut‐off for ade-
quate iodine intakes, whereas the value for the IFA group was less than
150 μg/L. None of the geometric means was close to being ≥500 μg/L,
the WHO cut‐off reflecting excessive iodine intakes.
Of the eight potential effect modifiers tested, three (gestational
age at enrolment, parity, and baseline UIC) had a significant interaction
with the intervention group (Table 3). There was a significanting pregnancy in the iLiNS DYAD‐Ghana trial, by groupa
MMN (n = 100) LNS (n = 101) p
119 (67, 203) 151 (88, 218)
39 (−34, 122) 14 (−64, 102)
161 (133, 184)f 158 (132, 185)f .004
162 (132, 182)f 159 (135, 186)f .001
trient Supplements; IFA = iron and folic acid; LNS = lipid‐based nutrient
ased nutrient supplements. Analysis at 36 weeks of gestation was based
cid per day; MMN group: Women were assigned to receive 18 vitamins and
receive 20 g SQ‐LNS per day with the same micronutrients as the MMN
trients.
ack‐transforming the log‐mean UIC after controlling for baseline UIC, with
th different superscript letters are significant different.
ck‐transforming log‐mean UIC after controlling for baseline UIC as well as
index, with Tukey adjustment for multiple comparison. Geometric mean
who received IFA, MMN, and SQ‐LNS during pregnancy in the iLiNS
, parity, and baseline UICa
MMNb LNSb pc pd
.022
156 (109, 223)f 106 (73, 146)e .021
157 (131, 187)f 171 (143, 203)f .015
.035
130 (98, 173) 117 (93, 153) .74
185 (144, 212)f 187 (149, 222)f .001
.021
210 (164, 268) 161 (131, 198) .059
132 (108, 161)f 156 (124, 198)f .025
= multiple micronutrients; SQ‐LNS = small‐quantity lipid‐based nutrient
tion was based on analysis of covariance (SAS PROC GLIMMIX).
cid per day; MMN group: Women were assigned to receive 18 vitamins and
receive 20 g SQ‐LNS per day with the same micronutrients as the MMN
trients.
iated with the outcome variable at α < .1 in bivariate analysis: baseline UIC,
dex. Geometric mean (95% CI) values with different superscript letters are
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tion among women enrolled in either the first or second trimester,
but the groups that differed varied: UIC was higher in those in the
MMN versus IFA group among those enrolled in the first trimester,
whereas it was higher in both the MMN and LNS groups, compared
with IFA, among those enrolled in the second trimester. With regard
to parity, intervention groups differed in UIC at 36 weeks among par-
ous women, but not among nulliparous women. Last, the effect of the
intervention group was more evident in those with baseline UIC
<150 μg/L than in those with higher baseline UIC.
The interaction between reported use of iodized salt and interven-
tion group was not significant. However, the likelihood that median
UIC would fall below the WHO cut‐off for adequacy differed depend-
ing on the reported use of iodized salt. At baseline, median UIC was
178 μg/L in women who reported using iodized salt usually or always
at either baseline or 36 weeks of gestation and 126 μg/L for women
who did not report using iodized salt usually or always at either time
point; within each of these categories of women, the median UICs of
the three intervention groups were comparable at baseline. At
36 weeks of gestation, median UIC among women who reported
using iodized salt usually or always at either time point was
188 μg/L in the IFA group, 228 μg/L in the MMN group, and
211 μg/L in the LNS group; among women who did not report using
iodized salt usually or always at either time point, median UIC was
86 μg/L in the IFA group, 137 μg/L in the MMN group, and
133 μg/L in the LNS group.4 | DISCUSSION
We found that in this semiurban setting in Ghana, the consumption of
SQ‐LNS or MMN, compared with IFA, during pregnancy increased
maternal UIC. At 36 weeks of gestation, the iodine status of women
provided with MMN or SQ‐LNS was adequate according to WHO‐
recommended cut‐off levels, whereas the iodine status of women
provided with IFA was insufficient. The impact of MMN or SQ‐LNS
consumption during pregnancy on UIC appeared to be greater in
parous than in nulliparous women.
We previously mentioned several strengths, as well as weak-
nesses, of our study (Adu‐Afarwuah et al., 2015; Adu‐Afarwuah
et al., 2017). The former include use of a fully randomized design and
blinding of laboratory analysts involved in the analysis of UIC. We paid
special attention to ensuring data quality. The study weaknesses
included our inability to fully blind all nonlaboratory study staff and
participants to the supplementation allocation because of the obvious
differences between the IFA and MMN capsules compared with the
SQ‐LNS sachets.
The WHO recommends the use of median UIC from spot urine
samples to describe iodine status in settings where salt iodization
programmes are in place (WHO, 2007). Median UICs from spot urine
samples (WHO, 2007) and the cut‐offs (WHO, 2013) are recom-
mended for assessing iodine intakes in populations (WHO, 2013). In
individuals, UICs are known to vary (between and within days) consid-
erably (Rasmussen, Ovesen, & Christiansen, 1999; WHO, 2007). We
did not examine the proportion of individuals within versus outsideof the adequate range for UIC because we had no data to estimate
and correct for day‐to‐day intraindividual variability.
Several previous trials have compared women given MMN includ-
ing iodine with those given IFA during pregnancy, including studies in
Pakistan (Bhutta et al., 2009), Guinea Bissau (Kaestel, Michaelsen,
Aaby, & Friis, 2005), Nepal (Osrin et al., 2005), Burkina Faso
(Roberfroid et al., 2008), Indonesia (Sunawang, Utomo, Hidayat,
Kusharisupeni, & Subarkah, 2009; Supplementation with Multiple
Micronutrients Intervention Trial Study et al., 2008), Bangladesh
(Eneroth et al., 2010), Niger (Zagre, Desplats, Adou, Mamadoultaibou,
& Aguayo, 2007), and China (Zeng et al., 2008), but we found only
one study that reported UIC: In Indonesia (Sunawang et al., 2009),
the investigators reported that “iodine levels increased” in pregnant
women receiving either the MMN supplement or IFA. It is unclear
what the magnitude of the increase was and what explained the
increase in UIC in the group receiving IFA. In the Rang‐Din Nutrition
Study (Mridha et al., 2017), the geometric mean UIC of the
Bangladeshi women (48 μg/L in early pregnancy and 29 μg/L at
36 weeks of gestation) was very low compared with that of the women
in Ghana, and there was no significant effect of SQ‐LNS containing
iodine on UIC. The investigators speculated that under such circum-
stances, the supplemental iodine was utilized in the thyroid gland, as
opposed to being excreted in the urine.
Although there are no universally accepted cut‐offs for defining
severe, moderate, or mild iodine deficiency in pregnant women based
on UICs, the observed UIC of women in the IFA group at 36
gestational weeks may suggest iodine deficiency (Zimmermann,
2007), particularly for those who did not report using iodized salt
usually or always. These results for the IFA group are comparable with
those from several iodine‐deficient countries, in which median UICs
during pregnancy have been found to be relatively low (Zimmermann,
2007). In contrast, the results for the MMN and LNS groups are similar
to those of longitudinal and cross‐sectional studies from several
iodine‐sufficient countries (where all salt is iodized, or dietary iodine
comes from either iodized salt or other food sources) in which the
median UICs during pregnancy were ≥140 μg/L (Zimmermann, 2007).
Median UIC of pregnant women recently reported for Ghana
(Iodine Global Network, 2017), which was based on a nationally
representative survey, suggests that at the national population level,
the iodine intakes of pregnant women are adequate. Our finding of
inadequate iodine intakes, based on UIC, among women in the IFA
group conflicts with this national report. It may be that the national
level UIC results (Iodine Global Network, 2017) obscure regional or
subregional disparities, which is common in such national cross‐
sectional surveys (Doggui, El Ati‐Hellal, Traissac, Lahmar, & El Ati,
2016). The study site is not a known iodine deficiency‐endemic area,
but much of the staple food consumed in the area comes from a
nearby mountainous district (Upper Manya Krobo District) and may
have low iodine content because of leaching from soil erosion
(Zimmermann, 2015). Consequently, the pregnant women in the
study area, who consume these staple foods, may have low iodine
status (Zimmermann, 2015).
The low geometric mean UIC of women in the IFA group, whose
supplement contained no iodine, may not be surprising. Since the
mid‐1990s, the national salt iodization programme in Ghana has been
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able progress has been made in reducing IDD. The implementation of
the programme has, however, been hampered by various challenges,
including the difficulty in acquiring the needed fortificant (potassium
iodate) and the large number of small‐scale salt producers, some of
whom have little or no capacity to iodize the salt they produce
(Nyumuah et al., 2012). The large percentage of households consuming
inadequately iodized salt observed in previous national surveys (GSS,
2011, GSS et al., 2015), and supported by findings from this study,
suggests that those challenges remain to some degree, despite
attempts at resolving them (Nyumuah et al., 2012), and as a result,
much of the salt produced in Ghana is still not iodized. Women know
that noniodized salt is cheaper and more accessible, compared with
the usually factory‐processed, fine‐textured, and branded iodized salt
(Agbozo, Dera, Gloverb, & Ellahi, 2016; Avinash & Prabha Adhikari,
2002; Knowles et al., 2017).
Thus, our results suggest that without iodine supplementation,
it is difficult for pregnant women in our study setting to achieve
adequate iodine status, unless they use iodized salt usually or
always during pregnancy. In fact, there are similar reports from
other countries showing low iodine status of pregnant women even
when a national salt iodization programme is in place (Mao et al.,
2015; Oral et al., 2016). We did not measure the iodine status of
infants born to women in our study, but in Morocco (Stinca et al.,
2017) the iodine status (as measured by total thyroxine) of infants
whose mothers were iodine deficient appeared to be worse than
that of the women themselves. Although the full impact of mild
iodine deficiency during pregnancy on fetal development may not
be known, the consequences could include increased risk of lower
verbal intelligence quotient later in life (Bath, Steer, Golding,
Emmett, & Rayman, 2013; Stinca et al., 2017). Maternal serum
thyroid hormone concentration or production may, however, be
normal even when mean UIC is as low as 33 μg/L (Cao et al.,
1994; Caron et al., 1997; Pedersen et al., 1993; Silva & Silva,
1981), although it is not certain what else may be affected when
UIC falls below the 150 μg/L WHO cut‐off.
Our results also suggest that ensuring adequate iodine status of
pregnant women in Ghana requires a policy for regular monitoring of
the iodine status of the population, especially pregnant women, in
addition to periodically determining the coverage of iodized salt
consumption at the household level (GSS et al., 2015, GSS, 2011).
Currently, the percentage of Ghanaian pregnant women showing
obvious signs of iodine deficiency is low (Government of Ghana,
2009), but a large number of women living in certain parts of the
country may be consuming insufficient iodine.
Results from subgroup analyses in randomized controlled trials
should be interpreted with caution (Brookes et al., 2001; Sedgwick,
2014); however, our subgroup analyses were prespecified (Brookes
et al., 2001; Moher et al., 2010; Sedgwick, 2014), and our finding
that MMN and SQ‐LNS consumption did not affect the UIC of
nulliparous women is presented to stimulate further investigation,
as it may reflect the greater vulnerability of nulliparous women
compared with their parous counterparts. As reported previously
(Adu‐Afarwuah et al., 2015), apart from being younger, the first‐
time mothers weighed less, had a lower mean haemoglobinconcentration, and were more likely to be anaemic or test positive
for malaria at baseline than parous women. It is possible that some
of these conditions, for example, increased risk of anaemia, could
have negatively affected the impact of MMN and SQ‐LNS supple-
mentation. In the Cote d'Ivoire (Zimmermann, Adou, Torresani,
Zeder, & Hurrell, 2000), iron deficiency anaemia weakened the
efficacy of iodine supplementation in goitrous children possibly by
reducing the activity of iron‐containing thyroid peroxidase (Hess,
Zimmermann, Arnold, Langhans, & Hurrell, 2002), which can impair
thyroid hormone production. The increased risk of anaemia and
malaria in nulliparous women also could have reduced iodine
intakes through the reduction of food consumption because of
anorexia or the cultural practice of withdrawal from food during
illness (Scrimshaw, 1992).
We conclude that in this semiurban setting in Ghana, the
iodine intakes of pregnant women appear to be insufficient despite
the national salt iodization programme and that the consumption of
SQ‐LNS or MMN supplements providing iodine at the current WHO‐
recommended daily dose increases the likelihood of adequate iodine
status. Although universal salt iodization remains to be achieved in
Ghana, supplementation with SQ‐LNS or MMN would ensure optimal
iodine status among pregnant women in this setting.
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